APM
KNTE

Avidity Partners Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Avidity Partners Management’s Portfolio KNTE Stock Details KNTE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,160,000
Closed -$7.25M – 109
2023
Q1 		$7.25M Sell
1,160,000
-52,700
-4% -$329K 0.24% 68
2022
Q4 		$7.4M Buy
1,212,700
+89
+0% +$543 0.16% 62
2022
Q3 		$14.5M Buy
+1,212,611
New +$14.5M 0.29% 61